Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | +8.33% | -1.52% | -8.45% |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-8.45% | 11.6M | |
-3.60% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive